| Literature DB >> 30324628 |
Xin Wang1, Mudan Ren1, Yarui Li1, Junbi Hu1, Guifang Lu1, Wenhui Ma1, Dan Guo1, Xinlan Lu1, Shuixiang He1.
Abstract
Increasing studies showed that long noncoding RNAs (lncRNAs) had crucial regulatory roles in various tumors, including gastric cancer (GC). Recent studies demonstrated that lncRNA nicotinamide nucleotide transhydrogenase-antisense RNA1 (NNT-AS1) played an important role in several tumors. However, the role and expression of NNT-AS1 in GC progression remain unknown. In our study, we indicated that NNT-AS1 expression was upregulated in GC samples compared with the nontumor tissues. We also showed that NNT-AS1 expression was upregulated in the GC cell lines. Ectopic expression of NNT-AS1 promoted GC cell line HGC-27 cell proliferation, cell cycle progression, and invasion. In addition, we showed that NNT-AS1 acted as a sponge competing endogenous RNA for microRNA-363 (miR-363), which was downregulated in the GC samples and cell lines. miR-363 expression was negatively related with NNT-AS1 expression in GC samples. Upregulated expression of miR-363 suppressed GC cell growth, cycle, and invasion. Furthermore, we reported that elevated expression of NNT-AS1 promoted GC cell proliferation, cycle, and invasion partly by suppressing miR-363 expression. These results indicated that lncRNA NNT-AS1 acted as an oncogene in the development of GC partly by inhibiting miR-363 expression.Entities:
Keywords: long noncoding RNAs; miR-363; nicotinamide nucleotide transhydrogenase-antisense RNA1
Mesh:
Substances:
Year: 2018 PMID: 30324628 DOI: 10.1002/jcb.27855
Source DB: PubMed Journal: J Cell Biochem ISSN: 0730-2312 Impact factor: 4.429